Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
In the last 90 days, Protara Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Protara Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +3 vs. Q3 2021
- Shares held
- 6.87M
- +597.3K (+9.5%) vs. Q3 2021
- Total value
- $46.5M
- +$3.07M (+7.1%) vs. Q3 2021
- New holders
- 7
- 13 more added
- Sold out
- 4
- 11 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,650,000 | $18.0M | 3.82% | +91,528+3.6% | Added |
| OrbiMed Advisors LLC | 830,641 | $5.61M | 0.07% | +380,641+84.6% | Added |
| Vanguard Group Inc | 435,251 | $2.94M | 0.00% | −562−0.1% | Reduced |
| Citadel Advisors LLC | 428,366 | $2.89M | 0.00% | +81,935+23.7% | Added |
| Perceptive Advisors LLC | 421,641 | $2.85M | 0.04% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 279,256 | $1.89M | 0.54% | −200,739−41.8% | Reduced |
| DLD Asset Management, LP | 229,231 | $1.55M | 0.13% | +229,231 | New |
| Boxer Capital, LLC | 209,227 | $1.41M | 0.06% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 199,671 | $1.35M | 0.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 197,302 | $1.33M | 0.00% | +41,329+26.5% | Added |
| Two Sigma Investments, LP | 190,278 | $1.28M | 0.00% | +59,343+45.3% | Added |
| Two Sigma Advisers, LP | 170,918 | $1.15M | 0.00% | +2,100+1.2% | Added |
| Millennium Management LLC | 106,245 | $717.0K | 0.00% | +1,327+1.3% | Added |
| Geode Capital Management, LLC | 79,017 | $533.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 64,800 | $437.0K | 0.00% | −51,100−44.1% | Reduced |
| Bridgeway Capital Management, LLC | 53,500 | $361.0K | 0.01% | −59,000−52.4% | Reduced |
| BlackRock Inc. | 40,140 | $271.0K | 0.00% | −3,896−8.8% | Reduced |
| Dimensional Fund Advisors LP | 33,474 | $226.0K | 0.00% | +33,474 | New |
| State Street Corp | 29,800 | $201.0K | 0.00% | +7,000+30.7% | Added |
| Sender Co & Partners, Inc. | 28,502 | $192.0K | 0.12% | +28,502 | New |
| Morgan Stanley | 27,900 | $188.0K | 0.00% | +1,318+5.0% | Added |
| Susquehanna International Group, LLP | 27,862 | $188.0K | 0.00% | +11,969+75.3% | Added |
| Boothbay Fund Management, LLC | 27,591 | $186.0K | 0.01% | −19,832−41.8% | Reduced |
| Northern Trust Corp | 22,215 | $150.0K | 0.00% | −64−0.3% | Reduced |
| Bank of New York Mellon Corp | 17,907 | $120.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 17,219 | $115.0K | 0.00% | +17,219 | New |
| Prelude Capital Management, LLC | 16,855 | $114.0K | 0.01% | +3,700+28.1% | Added |
| Trexquant Investment LP | 15,155 | $102.0K | 0.01% | +2,701+21.7% | Added |
| Gyon Technologies Capital Management, LP | 12,553 | $85.0K | 0.02% | +12,553 | New |
| Bank of America Corp | 6,878 | $47.0K | 0.00% | +6,356+1,217.6% | Added |
| JPMorgan Chase & Co | 1,103 | $7.00K | 0.00% | −6,937−86.3% | Reduced |
| Tower Research Capital LLC (TRC) | 799 | $6.00K | 0.00% | +799 | New |
| Simplex Trading, LLC | 575 | $3.00K | 0.00% | −6−1.0% | Reduced |
| Wells Fargo & Company | 560 | $3.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 174 | $1.00K | 0.00% | −2,426−93.3% | Reduced |
| Royal Bank of Canada | 159 | $1.00K | 0.00% | −505−76.1% | Reduced |
| Federated Hermes, Inc. | 130 | $1.00K | 0.00% | +130 | New |
| American Portfolios Advisors | 100 | $675 | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −23,955−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,130−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −15,190−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −14,500−100.0% | Sold out |
| Knott David M | – | – | – | – | Not filed |